Potential of plant-sourced phenols for inflammatory bowel disease.

Curr Med Chem. 2017 Oct 9. doi: 10.2174/0929867324666171009100900.
[Epub ahead of print]


PM 2 site 207Inflammatory bowel disease (IBD) is an uncontrolled chronic inflammatory intestinal disorder, which requires medications for long-term therapy. Facing the challenges of severe side effects and drug resistance of conventional medications, to develop the strategies meet the stringent safety and effectiveness in the long-term treatment are urgent in the clinics. In this regard, a growing body of evidence confirms plant-sourced phenols, such as flavonoids, catechins, stilbenes, coumarins, quinones, lignans, phenylethanoids, cannabinoid phenols, tannins, phenolic acids and hydroxyphenols, exert potent protective benefits with fewer undesirable effects in conditions of acute or chronic intestinal inflammation through improvement of colonic oxidative and pro-inflammatory status, preservation of the epithelial barrier function and modulation of gut microbiota. In this review, the great potential of plant-sourced phenols and their action mechanisms for the treatment or prevention of IBD in recent research are summarized, which may help the further development of new preventive/adjuvant regimens for IBD.


Inflammatory bowel disease; action mechanism.; plant-sourced phenols; therapeutic effects

PMID: 28990509


DOI: 10.2174/0929867324666171009100900
twin memes II

Tags: , , ,